The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Atezolizumab (atezo) + bevacizumab (bev) versus sunitinib (sun) in pts with untreated metastatic renal cell carcinoma (mRCC) and sarcomatoid (sarc) histology: IMmotion151 subgroup analysis.
 
Brian I. Rini
Consulting or Advisory Role - AVEO; Bristol-Myers Squibb; Merck; Novartis; Pfizer; Roche/Genentech; synthorx
Research Funding - AstraZeneca/MedImmune (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Pfizer
 
Robert J. Motzer
Consulting or Advisory Role - Eisai; Exelixis; Genentech/Roche; Incyte; Lilly; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); Novartis (Inst); Pfizer (Inst)
 
Thomas Powles
Honoraria - AstraZeneca; Bristol-Myers Squibb; MERCK; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Incyte; Ipsen; Merck; Novartis; Novartis; Pfizer; Seagen
Research Funding - AstraZeneca/MedImmune; Roche/Genentech
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis/Ipsen; Pfizer; Roche/Genentech
 
David F. McDermott
Consulting or Advisory Role - alkermes; Array BioPharma; Bristol-Myers Squibb; EMD Serono; exelixis; Genentech/Roche; Jounce Therapeutics; Lilly; Merck; Novartis; Peloton Therapeutics; Pfizer; X4 Pharma
Research Funding - alkermes (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Prometheus (Inst)
Other Relationship - Beth Israel Deaconess Medical Center; Various
 
Bernard Escudier
Honoraria - Bristol-Myers Squibb; EUSA Pharma; Ipsen; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - AVEO; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Novartis; Pfizer; Roche/Genentech
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Pfizer; Roche/Genentech
 
Frede Donskov
Research Funding - Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
 
Robert E. Hawkins
Employment - Cellular Therapeutics; Immetacyte
Leadership - Cellular Therapeutics; Immetacyte
Stock and Other Ownership Interests - Cellular Therapeutics; Immetacyte
Honoraria - Bristol-Myers Squibb; EUSA Pharma; GlaxoSmithKline; Ipsen; Novartis; pfizer
Patents, Royalties, Other Intellectual Property - Medical Research Council - Phage Antibody Patents
 
Sergio Bracarda
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Janssen Oncology; Roche/Genentech
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Janssen Oncology; MSD Oncology; Pfizer; Roche/Genentech
Travel, Accommodations, Expenses - Astellas Pharma; Exelixis/Ipsen; Ipsen; Novartis; Pfizer; Roche
 
Jens Bedke
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; MSD; Nektar; Novartis; Pfizer; Roche
Speakers' Bureau - Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; MSD; Novartis; Pfizer; Roche
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Ipsen (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Ugo De Giorgi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck; Pfizer; Sanofi
Research Funding - AstraZeneca (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Janssen; Pfizer
 
Camillo Porta
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; MSD; Novartis; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Eisai; EUSA Pharma; GE Healthcare; Ipsen; Janssen; MSD; Novartis; Pfizer
Expert Testimony - EUSA Pharma
 
Alain Ravaud
Honoraria - Bristol-Myers Squibb; Ipsen; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Ipsen; Novartis; Pfizer; Roche
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; ipsen; MSD; Novartis; Pfizer; Roche
 
Francis Parnis
Consulting or Advisory Role - Astellas Medivation; Ipsen; Janssen Oncology; Pfizer
Travel, Accommodations, Expenses - Amgen; Astellas Medivation; Ipsen
 
Enrique Grande
Honoraria - Advanced Accelerator Applications; Bristol-Myers Squibb; Celgene; Eisai; Eusa Pharma; Genzyme; IPSEN; Lexicon; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Roche
Consulting or Advisory Role - Ipsen; MSD; Pfizer
Research Funding - AstraZeneca (Inst); Ipsen (Inst); MTEM/Threshold (Inst); Pfizer (Inst); Roche
 
Wei Zhang
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
Travel, Accommodations, Expenses - Genentech/Roche
 
Mahrukh A. Huseni
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
Patents, Royalties, Other Intellectual Property - Genentech/Roche
 
Susheela Carroll
Employment - Genentech/Roche
Stock and Other Ownership Interests - Merrimack; Roche/Genentech
Consulting or Advisory Role - Ultragenyx Pharmaceuticals (I)
 
Roxana Ioana Sufan
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Travel, Accommodations, Expenses - Genentech
 
Christina Schiff
Employment - Genentech/Roche; Genentech/Roche (I)
Stock and Other Ownership Interests - Genentech/Roche; Genentech/Roche (I)
Patents, Royalties, Other Intellectual Property - Genentech/Roche
 
Michael B. Atkins
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Acceleron Pharma; Aduro Biotech; Agenus; Array BioPharma; Arrowhead Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Exelixis; Genentech; Glactone Pharma; Immunocore; Iovance Biotherapeutics; Merck; Newlink Genetics/Pharmatech; Novartis; Oncolys BioPharma; Pfizer; Surface Oncology; Werewolf Pharma; X4 Pharma
Research Funding - Bristol-Myers Squibb (Inst)